Narus Financial Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-900
| Closed | -$231K | – | 137 |
|
|
2023
Q3 | $231K | Hold |
900
| – | – | 0.12% | 112 |
|
|
2023
Q2 | $256K | Hold |
900
| – | – | 0.13% | 100 |
|
|
2023
Q1 | $250K | Sell |
900
-15
| -2% | -$4.17K | 0.14% | 97 |
|
|
2022
Q4 | $253K | Sell |
915
-20
| -2% | -$5.54K | 0.15% | 96 |
|
|
2022
Q3 | $250K | Buy |
+935
| New | +$250K | 0.16% | 90 |
|
|
2022
Q2 | – | Sell |
-971
| Closed | -$204K | – | 114 |
|
|
2022
Q1 | $204K | Buy |
+971
| New | +$204K | 0.11% | 108 |
|
|
2021
Q1 | $332K | Buy |
+1,187
| New | +$332K | 0.2% | 61 |
|
|
2019
Q4 | $273K | Hold |
920
| – | – | 0.19% | 59 |
|
|
2019
Q3 | $214K | Hold |
920
| – | – | 0.16% | 68 |
|
|
2019
Q2 | $215K | Buy |
+920
| New | +$215K | 0.17% | 67 |
|
|
2017
Q3 | $410K | Buy |
1,310
+140
| +12% | +$43.8K | 0.36% | 42 |
|
|
2017
Q2 | $317K | Hold |
1,170
| – | – | 0.29% | 47 |
|
|
2017
Q1 | $320K | Hold |
1,170
| – | – | 0.31% | 44 |
|
|
2016
Q4 | $332K | Buy |
+1,170
| New | +$332K | 0.35% | 44 |
|